These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1269779)

  • 21. Metiamide in the Zollinger-Ellison syndrome.
    Blair EL; Grund ER; Miller IT; Redd JD; Sanders DJ; Thompson MH; Venables CW
    Am J Dig Dis; 1975 Dec; 20(12):1123-30. PubMed ID: 1106187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment of systemic mastocytosis with histamine H2 receptor antagonists.
    Johnson GJ; Silvis SE; Roitman B; Blumenthal M; Gilbert HS
    Am J Gastroenterol; 1980 Dec; 74(6):485-9. PubMed ID: 6782861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of metiamide, an H2-receptor antagonist, in the prevention of experimental stress ulcers.
    Safaie-Shirazi S; Foster LD; Hardy BM
    Gastroenterology; 1976 Sep; 71(3):421-5. PubMed ID: 985775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of long-term metiamide treatment on gastric secretion and on mucosal cells in the rat].
    Witzel L; Halter F; Olah AJ
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():425-6. PubMed ID: 611996
    [No Abstract]   [Full Text] [Related]  

  • 25. Aspirin- and bile- induced acute erosive gastritis: its prevention by metiamide therapy.
    Mann NS; Sachdev AJ
    Arch Pathol Lab Med; 1977 Apr; 101(4):206-7. PubMed ID: 576788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New class of pharmacological preparations: histamine H2-receptors blockaders (a review of the literature)].
    Ionov ID
    Farmakol Toksikol; 1978; 41(5):624-32. PubMed ID: 81139
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of metiamide on gastric acid hypersecretion, steatorrhea, and bone-marrow function in a patient with systemic mastocytosis.
    Feldman EJ; Isenberg JI
    N Engl J Med; 1976 Nov; 295(21):1178-9. PubMed ID: 980022
    [No Abstract]   [Full Text] [Related]  

  • 28. Drugs for peptic ulcer.
    Clark CG; Wyllie JH
    World J Surg; 1977 Jan; 1(1):3-7. PubMed ID: 17229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of duodenal ulcer by metiamide. A multicentre trial.
    Lancet; 1975 Oct; 2(7939):779-81. PubMed ID: 78150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiarrhythmic action of metiamide in experimental cardiac arrhythmias.
    Soni RK; Pendse VK; Madan V; Madan BR
    Indian J Physiol Pharmacol; 1979; 23(1):55-6. PubMed ID: 35467
    [No Abstract]   [Full Text] [Related]  

  • 31. Value of metiamide in the preoperative management of the Zollinger-El.
    Smith ER; Cuthbert JA; McKessar JH; Francis PN; Little JM
    Med J Aust; 1976 Jun; 1(26):1000-1. PubMed ID: 979765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of metiamide in prevention of experimental stress ulcers.
    Foster LD; Safaie-Shirazi S
    Surg Forum; 1975; 26():360-1. PubMed ID: 1216158
    [No Abstract]   [Full Text] [Related]  

  • 33. Nocturnal metiamide treatment in the management of healed duodenal ulceration.
    Thompson MH; Venables CW; Smith PA; Walker W
    Gut; 1977 Jun; 18(6):438-41. PubMed ID: 326638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of metiamide, an antagonits of H-2 phistamine receptor, on the development of experimental peptic ulcer in rats].
    Bilski R; Kowalewski K
    Folia Med Cracov; 1977; 19(3):299-313. PubMed ID: 606636
    [No Abstract]   [Full Text] [Related]  

  • 35. Early clinical experience with metiamide, a histamine H2-receptor antagonist, in patients with duodenal ulcer.
    Thompson MH; Reed JD; Dale G; Venables CW
    Am J Dig Dis; 1975 Dec; 20(12):1135-41. PubMed ID: 1106188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of gastric secretion by anti-gastrinic and H2-blocking agents.
    Rovati AL
    Scand J Gastroenterol Suppl; 1976; 42():113-8. PubMed ID: 796963
    [No Abstract]   [Full Text] [Related]  

  • 37. Metiamide treatment in five patients with Zollinger-Ellison syndrome.
    Bonfils S; Bernier JJ; Mignon M; Lambert R; Bernades P; L'Hirondel C; Accary JP; Kloeti G
    Digestion; 1977; 15(1):43-52. PubMed ID: 838177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of duodenal ulceration produced by cysteamine or propionitrile: influence of vagotomy, sympathectomy, histamine depletion, H-2 receptor antagonists and hormones.
    Szabo S; Haith LR; Reynolds ES
    Dig Dis Sci; 1979 Jun; 24(6):471-7. PubMed ID: 37058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dose-response curves obtained with metiamide in the Zollinger-Ellison syndrome].
    Mignon M; Galmiche JP; Bonfils S
    Biol Gastroenterol (Paris); 1975; 8(3):239-44. PubMed ID: 764881
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of metiamide on gastric secretion and stress ulceration in rats.
    Dai S; Ogle CW; Lo CH
    Eur J Pharmacol; 1975; 33(2):277-82. PubMed ID: 1183477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.